UBS Group’s BlueLinx BXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-45,000
Closed -$641K 7979
2019
Q4
$641K Buy
+45,000
New +$923K ﹤0.01% 4613

Other funds holding BXC

UBS Group's BXC Position: Q1 2026 in Review

UBS Group reduced its BlueLinx (BXC) stake by 27% in Q1 2026, selling an estimated $263K and leaving 10,709 shares worth $580K. The position accounts for ﹤0.01% of the portfolio, ranked #5978.

UBS Group first reported a position in BXC in Q4 2014 and has held it in 40 quarters since. The position peaked at $5.16M in Q4 2024. 145 funds tracked by Wall St. Rank hold BXC as of Q1 2026.

  • UBS Group held 10,709 shares of BlueLinx worth $580K as of Q1 2026.
  • UBS Group sold 4,003 BlueLinx shares in Q1 2026, an estimated $263K.
  • BlueLinx made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5978 holding.
  • UBS Group first reported a position in BlueLinx in Q4 2014 and has held it in 40 quarters since.
  • UBS Group's BlueLinx position peaked at $5.16M in Q4 2024.
  • 145 funds tracked by Wall St. Rank held BlueLinx as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.